| Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4 X Dai, W Gan, X Li, S Wang, W Zhang, L Huang, S Liu, Q Zhong, J Guo, ... Nature medicine 23 (9), 1063-1071, 2017 | 290 | 2017 |
| Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation P Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye, S Wang, CW Pan, Y Zhu, ... Nature medicine 23 (9), 1055-1062, 2017 | 258 | 2017 |
| Proteomic characteristics of human sperm cryopreservation S Wang, W Wang, Y Xu, M Tang, J Fang, H Sun, Y Sun, M Gu, Z Liu, ... Proteomics 14 (2-3), 298-310, 2014 | 144 | 2014 |
| Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling JM Chan, S Zaidi, JR Love, JL Zhao, M Setty, KM Wadosky, A Gopalan, ... Science 377 (6611), 1180-1191, 2022 | 136 | 2022 |
| The need for urogenital tract monitoring in COVID-19 S Wang, X Zhou, T Zhang, Z Wang Nature Reviews Urology 17 (6), 314-315, 2020 | 103 | 2020 |
| Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity J Cyrta, A Augspach, MR De Filippo, D Prandi, P Thienger, M Benelli, ... Nature communications 11 (1), 5549, 2020 | 95 | 2020 |
| The potential of organoids in urological cancer research YC Shangqian Wang, Dong Gao Nat Rev Urol, 2017 | 91 | 2017 |
| Aberrant activation of a gastrointestinal transcriptional circuit in prostate cancer mediates castration resistance S Shukla, J Cyrta, DA Murphy, EG Walczak, L Ran, P Agrawal, Y Xie, ... Cancer cell 32 (6), 792-806. e7, 2017 | 78 | 2017 |
| Downregulation of hsa_circ_0000285 serves as a prognostic biomarker for bladder cancer and is involved in cisplatin resistance. BJ Chi, DM Zhao, L Liu, XZ Yin, FF Wang, S Bi, SL Gui, SB Zhou, WB Qin, ... Neoplasma 66 (2), 2019 | 72 | 2019 |
| The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer Y Yan, J Ma, D Wang, D Lin, X Pang, S Wang, Y Zhao, L Shi, H Xue, ... EMBO molecular medicine 11 (11), e10659, 2019 | 71 | 2019 |
| FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor L Ran, Y Chen, J Sher, EWP Wong, D Murphy, JQ Zhang, D Li, K Deniz, ... Cancer discovery 8 (2), 234-251, 2018 | 58 | 2018 |
| Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in PTEN‐ or SPOP‐mutated prostate cancer Y Yan, J An, Y Yang, D Wu, Y Bai, W Cao, L Ma, J Chen, Z Yu, Y He, X Jin, ... EMBO molecular medicine 10 (4), e8478, 2018 | 51 | 2018 |
| TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways C Liang, S Wang, C Qin, M Bao, G Cheng, B Liu, P Shao, Q Lv, N Song, ... Cell Death & Disease 9 (2), 155, 2018 | 49 | 2018 |
| Toxicity of polybrominated diphenyl ethers (PBDEs) on rodent male reproductive system: A systematic review and meta-analysis of randomized control studies T Zhang, X Zhou, A Xu, Y Tian, Y Wang, Y Zhang, Q Gu, SQ Wang, ... Science of the Total Environment 720, 137419, 2020 | 45 | 2020 |
| MicroRNA‑126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9 Y Hua, C Liang, C Miao, S Wang, S Su, P Shao, B Liu, M Bao, J Zhu, A Xu, ... Oncology letters 15 (6), 9051-9060, 2018 | 45 | 2018 |
| Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 entry molecules in the urinary tract and their associations with clinical manifestations of COVID-19 X Ren, S Wang, X Chen, X Wei, G Li, S Ren, T Zhang, X Zhang, Z Lu, ... Infection and Drug Resistance, 3977-3990, 2020 | 44 | 2020 |
| Pyrethroids toxicity to male reproductive system and offspring as a function of oxidative stress induction: rodent studies X Zhang, T Zhang, X Ren, X Chen, SQ Wang, C Qin Frontiers in Endocrinology 12, 656106, 2021 | 42 | 2021 |
| COL5A2 promotes proliferation and invasion in prostate cancer and is one of seven gleason-related genes that predict recurrence-free survival X Ren, X Chen, K Fang, X Zhang, X Wei, T Zhang, G Li, Z Lu, N Song, ... Frontiers in oncology 11, 583083, 2021 | 38 | 2021 |
| MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis B Wu, K Liu, H Huang, J Yuan, W Yuan, S Wang, T Chen, H Zhao, C Yin PLoS One 8 (12), e85166, 2013 | 38 | 2013 |
| PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis S Wang, Q Cao, X Wang, B Li, M Tang, W Yuan, J Fang, J Qian, C Qin, ... PloS one 8 (2), e56797, 2013 | 37 | 2013 |
